Facebook
Twitter
LinkedIn
Forward
AI in Healthcare
Purpose
Mary Greeley Medical Center Grand Rounds is a multi-disciplinary clinical activity that maintains, develops, or increases the knowledge, skills, professional performance, and relationships a physician uses to provide services for patients, the public, or the profession.
Target Audience
Physicians, advanced practice providers, nurses, medical students (rotating), non-medical students (rotating), and healthcare administrators.
Learning Objectives
- Describe the current state of (FDA regulated) AI in terms of evidence, regulation and reimbursement and the difference between assistive/augmentative and autonomous AI.
- Identify how trust in AI requires an ethical framework and regulation with reimbursement and policy built from that.
- Discuss where FDA regulated AI is likely going in the next five years.
Speaker
Michael D. Abràmoff, MD, PhD
Digital Diagnostics
University of Iowa Health Care, Department of Opthalmology and Visual Sciences
Education
- MD in Medicine, University of Amsterdam, Amsterdam, Netherlands
- PhD in Biomedical Imaging, University of Utrecht, Utrecht, Netherlands
- Clinical Epidemiology, Vrije Universiteit, Amsterdam, Netherlands
- Postdoctoral Fellow in Research Fellowship, RIKEN Neural Networks Research Laboratory, Wako-shi, Saitama Prefecture, Japan
- Resident in Surgery, University Hospital of Maastricht, Maastricht, Netherlands
- Resident in Ophthalmology, University Hospital of Utrecht, Utrecht, Netherlands
- Fellow in Medical Retina, Vrije Universiteit University Hospital, Amsterdam, Netherlands
- Fellow in Ophthalmology and Visual Sciences, University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Accreditation Statements
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
EDUCATIONAL GRANTS
No ineligible company provided financial support for this continuing education activity.
DISCLOSURES
The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.
- Michael D. Abràmoff, MD, PhD
o Founder, Director, Consultant and intellectual property: Digital Diagnostics
o Intellectual property: University of Iowa
CME Committee
- No Mary Greeley Medical Center CME Committee member who planned this activity has any financial relationship to disclose relating to the content.
Gifts to the Mary Greeley Medical Center Foundation from Mary Greeley Medical Center, McFarland Clinic, and Availa Bank support this program. The content and selection of speaker(s) is the responsibility of the Mary Greeley Medical Center for Continuing Medical Education Committee and not the sponsors of this program.
DISCLAIMER
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition. The content of this educational offering does not reflect the views of Des Moines University.
Available Credit
- 1.00 AOA Category 2A